Maharashtra, India

Rajendra Narayaurao Kankan

This inventor holds 1 USPTO granted patent. Top assignee: Cipla Limited. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajendra Narayaurao Kankan. Retrieved from https://idiyas.com/inventor/rajendra-narayaurao-kankan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rajendra Narayaurao Kankan: Innovator in Pharmaceutical Chemistry

Introduction

Rajendra Narayaurao Kankan is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of phthalanes. His work has implications for the development of important medications.

Latest Patents

Kankan holds a patent for the "Preparation of phthalanes." This patent describes a method for synthesizing Citalopram and other phthalanes by reacting a salt of a compound where R is halogen, trifluoromethyl, cyano, or R—CO—, with cuprous cyanide. He has 1 patent to his name, showcasing his innovative approach to chemical synthesis.

Career Highlights

Rajendra Kankan is associated with Cipla Limited, a leading pharmaceutical company known for its commitment to quality and innovation. His role at Cipla has allowed him to contribute to the development of various pharmaceutical products that enhance patient care.

Collaborations

Throughout his career, Kankan has collaborated with esteemed colleagues such as Yusuf Khwaja Hamied and Dhanmaraj Ramachandra Rao. These collaborations have fostered an environment of innovation and excellence in pharmaceutical research.

Conclusion

Rajendra Narayaurao Kankan is a distinguished inventor whose work in pharmaceutical chemistry has made a lasting impact. His contributions to the preparation of phthalanes exemplify the importance of innovation in the development of effective medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…